Árgentil Capital Management Limited, a boutique investment banking company, confirmed its equity investment in Sygen Pharmaceuticals Limited, which, along with other co-investors, was structured through the investment vehicle of the backers, Market Growth Partners.
Àrgentil has engaged in a management team-based transaction with a clear track record of over 155 years of directing and controlling FMCG businesses’ activities in Nigeria and other developing markets.
Companies such as Sygen, which can offer quality, inexpensive medicines to a wide domestic market, continue to have substantial growth opportunities in the healthcare and consumer sectors.
Àrgentil is actively invested in small and medium-sized companies through the Àrgentil Principal Investment Portfolio II (APIP II), which has so far completed five investments.
Investments from APIP II have won award recognition, including the Private Equity Africa 2019 Deal of the Year (Small Cap) award, and many of our investors have had a major positive impact on the existing COVID-19 climate.
Àrgentil is now widening its investment focus to include core West African countries through the US$95m Àrgentil SME Investment Fund (ASIF).
ASIF will invest in core development sectors such as Agriculture, Consumer Affairs, Technology and Energy. The initial national priority of ASIF will include Ghana, Liberia, Nigeria and Sierra Leone.
Àrgentil also makes direct contributions from its balance sheet to fund management teams or to sponsor emerging companies looking to develop networks that can expand over time to adopt key sectors’ development strategies.
Sygen is an indigenous pharmaceutical business that was founded in 2019 to purchase Nigerian German Chemicals’ main operating properties (NGC). NGC remained a well-known brand in Nigeria prior to its takeover, with operations lasting over 50 years.
Sygen manufactures and distributes prescription products under the brand name NGC targeting the segments of Analgesic, Anti-Diabetics, Antifungal, Anti-spasmodic, Cough narcotics and Hematinic medications.
The business also supplies drinks and bottled water. The business runs a warehouse in the state of Ogun, southwestern Nigeria, and eight depots nationwide.
The mission of Sygen is to create a leading pharmaceutical organisation based on the manufacture and delivery of inexpensive, high-quality medicines that are easily available and readily accessible to the economy’s middle and lower-income community.